Please assess the completion status of the following clinical trial:

Trial Title: Image-derived Prediction of Response to Chemo-radiation in Glioblastoma

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Histologically confirmed, primary supratentorial glioblastoma (WHO grade IV).~Exclusion Criteria:~* No informed consent can be obtained~* Inability to undergo MRI examination, due to metal implants, pacemaker etc.~* Not eligible for Stupp-regimen

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Standard chemoradiotherapy (Type: None): Group to receive 60 Gy radiotherapy in 30 fractions with concomitant and adjuvant temozolomide.

Based on this trial design, predict the completion outcome and termination type (if applicable).